BioImmune Introduces HeartOption.Business Editors/Medical Writers SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Oct. 10, 2001 BioImmune, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BIMM BIMM Brighton Institute of Modern Music (UK) BIMM British Institute of Musculoskeletal Medicine (Watford, Hertfordshire, UK) BIMM Business Image Management and Multimedia (course) ) announced today the addition of a new proprietary product HeartOption. The prospects of nutritional therapy for atherosclerosis and arteriolosclerosis have shown that a daily optimum intake of certain key nutrients is the primary solution for prevention and reversal of atherosclerosis and arteriolosclerosis. As stated in the Journal of Orthomolecular Medicine The Journal of Orthomolecular Medicine (JOM), first published in 1967, provides a source for publication of studies in nutritional and orthomolecular medicine. 1992; 7(1): 5-12 that using a specific nutrient program that attended to improving vascular health at a cellular level actually eradicated the cholesterol deposits within the vascular wall and reversed the growth of these deposits. The result was an improvement in the general health of the vascular system to the extent that the symptoms of atherosclerosis and arteriolosclerosis could disappear altogether. BioImmune, Inc. is currently planning to conduct clinical studies with the HeartOption product. These clinical studies with collaboration from Board Certified board certified, adj the status of a dental specialist such as an orthodontist who has become a board diplomate by successfully completing the certification program of the recognized certification board in that area of practice. Cardiologists and physicians will strengthen the scientific evidence supporting this unique product. HeartOption contains over 60 vitamins, phytonnutrients (plant nutrients), minerals, amino acids and trace elements that are vital for your cardiovascular health which can assist you in attaining your optimal level of cardiac function. Arnold Takemoto, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of BioImmune said, "We have not previously seen a product this comprehensive in regards to cardiovascular health. The implication for the widespread use of BioImmune's HeartOption product can begin to address this nation's staggering problem with heart disease." The unique design of HeartOption places this product in a category by itself by being comprehensive, readily assimilated, and easy-to-use. The target areas of HeartOption can be divided into six general categories: general nutrition, ATP ATP: see adenosine triphosphate. ATP in full adenosine triphosphate Organic compound, substrate in many enzyme-catalyzed reactions (see catalysis) in the cells of animals, plants, and microorganisms. production and metabolism, homocysteine Homocysteine Definition Homocysteine is a naturally occurring amino acid found in blood plasma. High levels of homocysteine in the blood are believed to increase the chance of heart disease, stroke, Alzheimer's disease, and osteoporosis. metabolism, lipoprotein lipoprotein (lĭp'əprō`tēn), any organic compound that is composed of both protein and the various fatty substances classed as lipids, including fatty acids and steroids such as cholesterol. , reduction, antioxidant antioxidant, substance that prevents or slows the breakdown of another substance by oxygen. Synthetic and natural antioxidants are used to slow the deterioration of gasoline and rubber, and such antioxidants as vitamin C (ascorbic acid), butylated hydroxytoluene function, maintenance of serum viscosity, and vascular health. HeartOption is more than just a multivitamin-mineral combination. By maintaining an optimum supply of targeted nutrition agents in the body, such as B vitamins, amino acids, and select minerals, the body will be able to selectively absorb the correct nutrients and optimize results. This product is a nutritionally complete dietary supplement for any person concerned with cardiovascular health. For more information on the HeartOption Product please visit the company's website at: www.bioimmune.com For corporate information about BioImmune, Inc. call Al Marchi (480/949-7965) or log-on to www.otcinfo.net Statements, which are not historical facts, are forward-looking statements. The Company, through its management makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors which could cause actual results to differ materially from those estimated by the Company include, but not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. , competition and other factors which may be identified from time to time in the Company's public announcements. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion